Combe Company Profile
✉ Email this page to a colleague
What is the competitive landscape for COMBE
COMBE has four approved drugs.
Drugs and US Patents for Combe
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Combe | VAGISTAT-1 | tioconazole | OINTMENT;VAGINAL | 020676-001 | Feb 11, 1997 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Combe | BACITRACIN | bacitracin | OINTMENT;TOPICAL | 062799-001 | May 14, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Combe | LANABIOTIC | bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate | OINTMENT;TOPICAL | 062499-001 | Jun 3, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

